Simian human immunodeficiency virus

Karlsson GB, Halloran M, Schenten D, Lee J, Racz P, Tenner-Racz K, Manola J, Gelman R, Etemad-Moghadam B, Desjardins E, Wyatt R, Gerard NP, Marcon L, Margolin D, Fanton J, Axthelm MK, Letvin NL, Sodroski J (1998) The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian- human immunodeficiency virus-infected macaques. J Exp Med 188 1159-1171... 

Sui Y, Potula R, Dhillon N, Pinson D, Li S, Nath A, Anderson C, Turchan J, Kolson D, Narayan O, Buch S (2004) Neuronal apoptosis is mediated by CXCLIO overexpression in simian human immunodeficiency virus encephalitis. Am J Pathol 164(5) 1557-1566... 

Kumar R, Torres C, Yamamura Y, Rodriguez 1, Martinez M, Staprans S, Donahoe RM, Kraiselburd E, Stephens EB, Kumar A (2004) Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus. J Virol 78 11425-11428... 

Harouse JM, Buckner C, Gettie A, et al. CD8+ T cell-mediated CXC chemokine receptor 4-simian/human immunodeficiency virus suppression in dually infected rhesus macaques. Proc Natl Acad Sci U S A 2003 100(19) 10977-10982. 

Veazey, R. S., Ling, B., Green, L. C., Ribka, E. P., Lifeon, J. D., Piatak, M., Jr., et al. (2009). Topically applied recombinant chemokine analogues fuUy protect macaques from vaginal simian-human immunodeficiency virus chaUenge. The Journal of Infectious Diseases, 199, 1525-1527. 

Matano, T, R. Shibata, C. Siemon, M. Connors, H.C. Lane, and M.A. Martin. Administration of an Anti-CD8 Monoclonal Antibody Interferes With the Clearance of Chimeric Simian/Human Immunodeficiency Virus During Primary Infections of Rhesus Macaques. / V/w/72 164—169(1998). 

Ebnet K, Kaldjian EP, Anderson AO, Shaw S (1996) Orchestrated information transfer underlying leukocyte endothelial interactions. Annu Rev Immunol 14 155-177 Edinger AL, Blanpain C, Kunstman KJ, Wohnsky SM, Parmentier M, Dorns RW (1999) Functional dissection of CCR5 coreceptor function through the use of CD4-independent simian immunodeficiency virus strains. J Virol 73(5) 4062 073 Edwards TG, Hoffman TL, Baribaud E, Wyss S, LaBranche CC, Romano J, Adkinson J, Sharron M, Hoxie JA, Dorns RW (2001) Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein. J Virol 75(ll) 5230-5239... 

Zhang L, He T, Talal A, Wang G, Frankel SS, Ho DD (1998) In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors CXCR4, CCR3, and CCR5. J Virol 72(6) 5035-5045... 

Arthos J, Rubbert A, Rabin RL, et al. CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopes. J Virol 2000 74(14) 6418-6424. 

Zolotukhin, A.S., Valentin, A., Pavlakis, G.N. and Felber, B.K. (1994) Continuous propagation of RRE(-) and Rev(-) RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes. J. Virol, 68, 7944-7952. 

Deng, H. K., Unutmaz, D., KewalRamani, V. N., and Littman, D. R. (1997) Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388, 296-300. 

Yamamoto et al. have reported that Ki 3 [Ce(SiWi 1039)2] shows inhibitory action to the human immunodeficiency virus (HIV) and the simian immunodeficiency virus [93]. 

HIV-1 human immunodeficiency virus-1, SIV simian immunodeficiency virus, MLV murine leukaemia virus, MMLV Moloney MLV, MPMV Mason-Pfizer monkey virus. 

Zink MC, Clements JE (2002) A novel simian immunodeficiency virus model tliat provides insiglit into mechanisms of human immunodeficiency virus centi al nervous system disease. J Neurovirol 8(Suppl 2) 42-48. 

Various bacterial vectors have been used to express a number of bacterial B. pertussis, S. pneumoniae, Y. pestis, and L. monocytogenes), viral (herpesvirus, influenza virus, human immunodeficiency virus, simian immunodeficiency virus, and hepatitis B virus), and parasitic (5. mansoni, and L. major) antigens. Significant improvements in attenuation of bacteria, and the stability, localization, and expression levels of heterologous antigens are required to market the bacterial vector-based vaccines for use in humans or animals. 

Goujon, C., L. Jarrosson-Wuilleme, et al. 2003. Heterologous human immunodeficiency virus type 1 lentiviral vectors packaging a simian immunodeficiency virus-derived genome dis-... 

Edinger AL, Mankowski JL, Doranz BJ, et al. CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain. Proc Natl Acad Sci USA 1997 94 14742-14747. Dumonceaux J, Nisole S, Chanel C, et al. Spontaneous mutations in the env gene of the human immunodeficiency virus type 1 NDK isolate are associated with a CD4-independent entry phenotype. J Virol 1998 72 512-519. 

Banner N, Schenten D, Craig S, Sodroski J. The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses. J Virol 2000 74 10984-10993. 

---